Lloyd’s Newsletter

Lloyd’s Newsletter

Share this post

Lloyd’s Newsletter
Lloyd’s Newsletter
IVERMECTIN and FENBENDAZOLE Testimonial - 46 year old patient Stage 4 Breast Cancer metastatic to bone not responding to mainstream or Integrative therapy, sees massive drop in cancer blood markers

IVERMECTIN and FENBENDAZOLE Testimonial - 46…

Lloyd Miller
Jan 21
1

Share this post

Lloyd’s Newsletter
Lloyd’s Newsletter
IVERMECTIN and FENBENDAZOLE Testimonial - 46 year old patient Stage 4 Breast Cancer metastatic to bone not responding to mainstream or Integrative therapy, sees massive drop in cancer blood markers
2

by Dr. William Makis MD

Read →
Comments
User's avatar
© 2025 Lloyd Miller
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share